MDP vs. CWEB, LABS, WLLW, VPH, HLS, HBP, MBX, BCT, and APS
Should you be buying Medexus Pharmaceuticals stock or one of its competitors? The main competitors of Medexus Pharmaceuticals include Charlotte's Web (CWEB), MediPharm Labs (LABS), Willow Biosciences (WLLW), Valeo Pharma (VPH), HLS Therapeutics (HLS), Helix BioPharma (HBP), Microbix Biosystems (MBX), BriaCell Therapeutics (BCT), and Aptose Biosciences (APS). These companies are all part of the "medical" sector.
Charlotte's Web (TSE:CWEB) and Medexus Pharmaceuticals (TSE:MDP) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, community ranking, risk, media sentiment, profitability and institutional ownership.
In the previous week, Charlotte's Web had 3 more articles in the media than Medexus Pharmaceuticals. MarketBeat recorded 3 mentions for Charlotte's Web and 0 mentions for Medexus Pharmaceuticals. Medexus Pharmaceuticals' average media sentiment score of 0.58 beat Charlotte's Web's score of 0.00 indicating that Charlotte's Web is being referred to more favorably in the media.
5.2% of Charlotte's Web shares are held by institutional investors. Comparatively, 11.4% of Medexus Pharmaceuticals shares are held by institutional investors. 11.2% of Charlotte's Web shares are held by insiders. Comparatively, 8.7% of Medexus Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Charlotte's Web has a beta of 2.23, indicating that its share price is 123% more volatile than the S&P 500. Comparatively, Medexus Pharmaceuticals has a beta of 1.85, indicating that its share price is 85% more volatile than the S&P 500.
Medexus Pharmaceuticals has higher revenue and earnings than Charlotte's Web. Charlotte's Web is trading at a lower price-to-earnings ratio than Medexus Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.
Medexus Pharmaceuticals received 1 more outperform votes than Charlotte's Web when rated by MarketBeat users. Likewise, 100.00% of users gave Medexus Pharmaceuticals an outperform vote while only 0.00% of users gave Charlotte's Web an outperform vote.
Medexus Pharmaceuticals has a net margin of 5.08% compared to Medexus Pharmaceuticals' net margin of -37.68%. Charlotte's Web's return on equity of 26.14% beat Medexus Pharmaceuticals' return on equity.
Summary
Medexus Pharmaceuticals beats Charlotte's Web on 11 of the 16 factors compared between the two stocks.
Get Medexus Pharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for MDP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MDP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Medexus Pharmaceuticals Competitors List
Related Companies and Tools
